Search

everythinglearnresearchcommunity

for

Search:↓

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Metformin can cause hair loss in some women with PCOS.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Girls with Pilonidal Disease are more likely to have Polycystic Ovarian Syndrome, and treating PCOS may reduce the need for PD intervention.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Adolescents with abnormal uterine bleeding often have polycystic ovarian syndrome and insulin resistance.

Hormonal imbalances in Polycystic Ovarian Syndrome (PCOS) might trigger a rare skin disorder called Confluent and Reticulated Papillomatosis (CRP), so dermatologists should consider checking for PCOS in CRP patients.

Traditional Chinese Medicine and acupuncture may improve Polycystic Ovarian Syndrome symptoms and reduce costs, but more research is needed.

The most common skin problems in polycystic ovarian disease are hirsutism and acne, and managing these symptoms is key for treatment.

About 15% of adolescent girls in a region of India have Polycystic Ovarian Syndrome, which is more common in those born by cesarean, with wisdom teeth, or with central obesity.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Evaluating various physical and health factors helps diagnose polycystic ovarian syndrome (PCOS).

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

PCOS is linked to low-grade chronic inflammation.

Female pattern hair loss is common in women with polycystic ovarian syndrome.